Reduced epinephrine reserve in response to insulin-induced hypoglycemia in patients with pituitary adenoma.
OBJECTIVE
Hypoglycemia induces rapid secretion of counterregulatory hormones such as catecholamine, glucagon, cortisol, and GH. Insulin-induced hypoglycemia is used for evaluating GH-IGF-I and ACTH-adrenal axes in patients with pituitary disorders. The aim of this study was to determine whether the response of catecholamine secretion to hypoglycemia is disrupted in patients with pituitary adenoma.


METHODS
The study population comprised 23 patients with pituitary adenoma (non-functioning adenoma or prolactinoma). An insulin tolerance test was performed and serum catecholamines as well as plasma GH and serum cortisol were measured.


RESULTS
The study patients showed diminished response of plasma epinephrine to insulin-induced hypoglycemia. With the cutoff level of peak epinephrine for defining severe impairment set at 400 pg/ml, more patients with secondary adrenal insufficiency showed severe impairment of the epinephrine response than did those without it. Peak epinephrine levels to insulin-induced hypoglycemia were significantly correlated with peak cortisol levels. In patients with secondary hypothyroidism, secondary hypogonadism, GH deficiency, or diabetes insipidus, the prevalence of severe impairment of the epinephrine response was similar to that in patients without these deficiencies.


CONCLUSIONS
Impaired epinephrine secretion in response to insulin-induced hypoglycemia was frequently observed in patients with pituitary adenoma. This disorder was especially severe in patients with secondary adrenal insufficiency.
Morita
Shinya
S
Department of Medicine, Osaka University Graduate School of Medicine, Yamada-Oka, Suita, Osaka, Japan.
Otsuki
Michio
M
Izumi
Maki
M
Asanuma
Nobuyuki
N
Izumoto
Shuichi
S
Saitoh
Youichi
Y
Yoshimine
Toshiki
T
Kasayama
Soji
S
D000236:Adenoma / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D000309:Adrenal Insufficiency / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D004837:Epinephrine / Q000097:blood*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000097:blood* / Q000139:chemically induced; D007004:Hypoglycemic Agents; D007328:Insulin; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010911:Pituitary Neoplasms / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D015175:Prolactinoma / Q000097:blood / Q000150:complications / Q000175:diagnosis; D012720:Severity of Illness Index
D015415:Biomarkers; D007004:Hypoglycemic Agents; D007328:Insulin; D009638:Norepinephrine; D004837:Epinephrine